Published in Chest on April 01, 2000
Promotion of lung health: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc (2014) 0.93
Descriptors and perception of dyspnea in African-American asthmatics. J Asthma (2007) 0.88
Differing reports of asthma symptoms in African Americans and Caucasians. J Asthma (2008) 0.87
Safety assessment of inhaled xylitol in mice and healthy volunteers. Respir Res (2004) 0.86
Relationship between Respiratory Load Perception and Perception of Nonrespiratory Sensory Modalities in Subjects with Life-Threatening Asthma. Pulm Med (2012) 0.78
Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax (1999) 3.00
Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med (1993) 2.77
Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ (2002) 2.35
Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev (2005) 2.32
A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients. Chest (2001) 2.00
[The treatment of asthma: indications for a change in approach]. Ned Tijdschr Geneeskd (2006) 1.95
Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project. Eur Urol (2002) 1.91
Use of out of hours services: a comparison between two organisations. Emerg Med J (2003) 1.89
[Recent changes in the prevalence of asthma in children]. Ned Tijdschr Geneeskd (2006) 1.89
Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? Br J Gen Pract (1996) 1.85
Self-management of asthma in general practice, asthma control and quality of life: a randomised controlled trial. Thorax (2003) 1.84
Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. Am J Respir Crit Care Med (1998) 1.77
Spirometry in general practice: the performance of practice assistants scored by lung function technicians. Br J Gen Pract (1997) 1.71
Biomarker reproducibility in exhaled breath condensate collected with different condensers. Eur Respir J (2008) 1.70
Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax (2003) 1.70
A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1. Eur Respir J (1992) 1.69
Can small group education and peer review improve care for patients with asthma/chronic obstructive pulmonary disease? Qual Health Care (1999) 1.66
Effects of physical activity in mild to moderate COPD: a systematic review. Br J Gen Pract (2002) 1.66
A model to evaluate quality and effectiveness of disease management. Qual Saf Health Care (2008) 1.55
Impact of a spirometry expert system on general practitioners' decision making. Eur Respir J (2007) 1.52
Trends in the prevalence of respiratory symptoms and treatment in Dutch children over a 12 year period: results of the fourth consecutive survey. Thorax (2005) 1.52
COPD screening in general practice using a telephone questionnaire. COPD (2010) 1.49
Global condensation: a "climate change" towards better standardisation of exhaled breath condensate measurements. Eur Respir J (2008) 1.48
Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD? Eur Respir J (2000) 1.48
Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients. Eur Respir J (1999) 1.48
Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction (2005) 1.47
Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J (1992) 1.46
[The efficacy of smoking cessation methods available in the Netherlands: a systematic review based on Cochrane data]. Ned Tijdschr Geneeskd (2003) 1.45
If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands. Addiction (2010) 1.42
Accuracy, precision and linearity of the portable flow-volume meter Microspiro HI-298. Eur Respir J (1991) 1.40
[Uneasiness about the safety of bupropion as an aid to smoking cessation unjustified ]. Ned Tijdschr Geneeskd (2001) 1.39
Mini-Wright peak flow meters are reliable after 5 years use. Dutch CNSLD Study Group. Eur Respir J (1997) 1.39
[Drug treatment of chronic obstructive pulmonary disease]. Ned Tijdschr Geneeskd (1996) 1.39
Endotoxin exposure as a major determinant of lung function decline in pig farmers. Am J Respir Crit Care Med (1998) 1.38
Are patients with COPD psychologically distressed? Eur Respir J (2005) 1.35
External validation of a COPD diagnostic questionnaire. Eur Respir J (2007) 1.33
Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS One (2012) 1.24
Do patients with COPD benefit from treatment with inhaled corticosteroids? Eur Respir J (1996) 1.23
Longitudinal changes in bronchial responsiveness associated with swine confinement dust exposure. Chest (2000) 1.23
Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2003) 1.20
Dynamics of brain extracellular fluid pH and phrenic nerve activity in cats after end-tidal CO2 forcing. Respir Physiol (1982) 1.16
Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract (2008) 1.14
Relation of the perception of airway obstruction to the severity of asthma. Thorax (1999) 1.14
Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med (2005) 1.13
Volumetric measurements of peripheral oedema in clinical conditions. Clin Physiol (2000) 1.12
Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patients. Fam Pract (2005) 1.12
Multifaceted support to improve clinical decision making in diabetes care: a randomized controlled trial in general practice. Diabet Med (2002) 1.12
Introduction of diabetes passports involving both patients and professionals to improve hospital outpatient diabetes care. Diabetes Res Clin Pract (2005) 1.10
Interleukin 13, CD14, pet and tobacco smoke influence atopy in three Dutch cohorts: the allergenic study. Eur Respir J (2008) 1.10
Effects of hypercapnia and hypocapnia on respiratory resistance in normal and asthmatic subjects. Thorax (1991) 1.09
House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: a possible delay in the manifestation of clinical asthma? J Allergy Clin Immunol (1997) 1.09
Target-flow inspiratory muscle training during pulmonary rehabilitation in patients with COPD. Chest (1991) 1.08
Intensive support to improve clinical decision making in cardiovascular care: a randomised controlled trial in general practice. Qual Saf Health Care (2003) 1.08
The effectiveness of psychosocial interventions delivered by general practitioners. Cochrane Database Syst Rev (2003) 1.08
Anxiety and depression in the working population using the HAD Scale--psychometrics, prevalence and relationships with psychosocial work characteristics. Soc Psychiatry Psychiatr Epidemiol (2004) 1.06
Health problems and psychosocial work environment as predictors of long term sickness absence in employees who visited the occupational physician and/or general practitioner in relation to work: a prospective study. Occup Environ Med (2003) 1.06
TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopy. Allergy (2009) 1.05
Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol (1999) 1.05
Respiratory morbidity in relationship to farm characteristics in swine confinement work: possible preventive measures. Am J Ind Med (1996) 1.03
Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis. Thorax (1999) 1.02
Health-based selection for asthma, but not for chronic bronchitis, in pig farmers: an evidence-based hypothesis. Eur Respir J (1999) 1.02
Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database Syst Rev (2006) 1.02
Effects of respiratory and (isocapnic) metabolic arterial acid-base disturbances on medullary extracellular fluid pH and ventilation in cats. Respir Physiol (1983) 0.98
Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur Respir J (2009) 0.98
The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review. Respir Med (2004) 0.97
Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J (1998) 0.96
The PREVASC study: the clinical effect of a multifaceted educational intervention to prevent childhood asthma. Eur Respir J (2005) 0.96
Factors associated with asthma control. J Asthma (2005) 0.95
Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J (1997) 0.95
Exacerbations and associated healthcare cost in patients with COPD in general practice. Monaldi Arch Chest Dis (2006) 0.92
The role of "fear of corticosteroids" in nonparticipation in early intervention with inhaled corticosteroids in asthma and COPD in general practice. Eur Respir J (1998) 0.92
Psychosocial interventions by general practitioners. Cochrane Database Syst Rev (2007) 0.91
Training of the respiratory muscles in individuals with tetraplegia. Spinal Cord (1999) 0.91
Exercise cardiorespiratory function before and one year after operation for pectus excavatum. J Thorac Cardiovasc Surg (1994) 0.91
Assessing the quality of life of adults with chronic respiratory diseases in routine primary care: construction and first validation of the 10-Item Respiratory Illness Questionnaire-monitoring 10 (RIQ-MON10). Qual Life Res (2004) 0.91
Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma. Eur Respir J (1989) 0.90
Reproducibility of incremental maximal cycle ergometer tests in patients with mild to moderate obstructive lung diseases. Lung (1989) 0.90
Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients. Eur J Clin Pharmacol (1984) 0.90
Perception of bronchoconstriction in asthma patients measured during histamine challenge test. Eur Respir J (1999) 0.90
Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers. Eur Respir J (2001) 0.90
The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program. Am J Respir Crit Care Med (2001) 0.90
Bottom-up implementation of disease-management programmes: results of a multisite comparison. BMJ Qual Saf (2011) 0.89
Regional differences in cardiovascular risk factor profile cannot fully explain differences in cardiovascular morbidity in the Netherlands: a comparison of two urban areas. Neth J Med (2005) 0.89
X-chromosome Forkhead Box P3 polymorphisms associate with atopy in girls in three Dutch birth cohorts. Allergy (2009) 0.88